{"data":[{"accessionNo":"0002052113-26-000835","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000899923","issuerName":"MYRIAD GENETICS INC","ticker":"MYGN","cusip":"62855J104","securityClass":"Common Stock","eventDate":"2026-08-31","reportingPerson":"BlackRock Portfolio Management LLC","reportingCik":null,"personType":"HC","sharesOwned":9900937,"percentOfClass":10.4,"filedAt":"2026-09-04"},{"accessionNo":"0000902664-26-003504","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000899923","issuerName":"MYRIAD GENETICS INC","ticker":"MYGN","cusip":"62855J104","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"Vestal Point Capital, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":5735000,"percentOfClass":6.1,"filedAt":"2026-08-14"},{"accessionNo":"0000902664-26-003504","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000899923","issuerName":"MYRIAD GENETICS INC","ticker":"MYGN","cusip":"62855J104","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"Ryan Wilder","reportingCik":null,"personType":"HC,IN","sharesOwned":5735000,"percentOfClass":6.1,"filedAt":"2026-08-14"},{"accessionNo":"0000905148-26-003766","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000899923","issuerName":"MYRIAD GENETICS INC","ticker":"MYGN","cusip":"62855J104","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"GLENVIEW CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14"},{"accessionNo":"0000905148-26-003766","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000899923","issuerName":"MYRIAD GENETICS INC","ticker":"MYGN","cusip":"62855J104","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"ROBBINS LARRY","reportingCik":null,"personType":"IN,HC","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14"},{"accessionNo":"0000093751-26-000498","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000899923","issuerName":"MYRIAD GENETICS INC","ticker":"MYGN","cusip":"62855J104","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":4985060,"percentOfClass":5.3,"filedAt":"2026-08-07"},{"accessionNo":"0000093751-26-000270","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000899923","issuerName":"MYRIAD GENETICS INC","ticker":"MYGN","cusip":"62855J104","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":4424027,"percentOfClass":4.7,"filedAt":"2026-05-12"},{"accessionNo":"0002012383-26-001053","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000899923","issuerName":"MYRIAD GENETICS INC","ticker":"MYGN","cusip":"62855J104","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":7976163,"percentOfClass":8.5,"filedAt":"2026-04-07"},{"accessionNo":"0000102909-26-001829","formType":"SCHEDULE 13G/A","amendmentNo":14,"issuerCik":"0000899923","issuerName":"Myriad Genetics Inc","ticker":"MYGN","cusip":"62855J104","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27"},{"accessionNo":"0001104659-26-013531","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000899923","issuerName":"Myriad Genetics, Inc.","ticker":"MYGN","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-31","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":6700158,"percentOfClass":7.2,"filedAt":"2026-02-11"},{"accessionNo":"0001104659-26-013531","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000899923","issuerName":"Myriad Genetics, Inc.","ticker":"MYGN","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-31","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":6700158,"percentOfClass":7.2,"filedAt":"2026-02-11"},{"accessionNo":"0001104659-26-013531","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000899923","issuerName":"Myriad Genetics, Inc.","ticker":"MYGN","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-31","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":6700158,"percentOfClass":7.2,"filedAt":"2026-02-11"},{"accessionNo":"0001104659-26-013531","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000899923","issuerName":"Myriad Genetics, Inc.","ticker":"MYGN","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-31","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":5183588,"percentOfClass":5.6,"filedAt":"2026-02-11"},{"accessionNo":"0000093751-26-000072","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000899923","issuerName":"MYRIAD GENETICS INC","ticker":"MYGN","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":5966567,"percentOfClass":6.4,"filedAt":"2026-02-09"},{"accessionNo":"0000905148-26-000161","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000899923","issuerName":"MYRIAD GENETICS INC","ticker":"MYGN","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-01-06","reportingPerson":"ROBBINS LARRY","reportingCik":null,"personType":"IN,HC","sharesOwned":4941058,"percentOfClass":5.3,"filedAt":"2026-01-13"},{"accessionNo":"0000905148-26-000161","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000899923","issuerName":"MYRIAD GENETICS INC","ticker":"MYGN","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-01-06","reportingPerson":"GLENVIEW CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":4941058,"percentOfClass":5.3,"filedAt":"2026-01-13"},{"accessionNo":"0001104659-25-110358","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000899923","issuerName":"Myriad Genetics, Inc.","ticker":"MYGN","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":4748327,"percentOfClass":5.1,"filedAt":"2025-11-12"},{"accessionNo":"0001104659-25-110358","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000899923","issuerName":"Myriad Genetics, Inc.","ticker":"MYGN","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":4748327,"percentOfClass":5.1,"filedAt":"2025-11-12"},{"accessionNo":"0001104659-25-110358","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000899923","issuerName":"Myriad Genetics, Inc.","ticker":"MYGN","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":4748327,"percentOfClass":5.1,"filedAt":"2025-11-12"},{"accessionNo":"0001104659-25-110358","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000899923","issuerName":"Myriad Genetics, Inc.","ticker":"MYGN","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":4466176,"percentOfClass":4.8,"filedAt":"2025-11-12"},{"accessionNo":"0000312069-25-000583","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000899923","issuerName":"MYRIAD GENETICS INC","ticker":"MYGN","cusip":null,"securityClass":"COMMON-STOCK","eventDate":"2025-09-30","reportingPerson":"Barclays PLC","reportingCik":null,"personType":"HC","sharesOwned":3939238,"percentOfClass":4.23,"filedAt":"2025-11-12"},{"accessionNo":"0000102909-25-000267","formType":"SCHEDULE 13G/A","amendmentNo":13,"issuerCik":"0000899923","issuerName":"Myriad Genetics Inc","ticker":"MYGN","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":7882515,"percentOfClass":8.47,"filedAt":"2025-10-31"}],"updatedAt":"2026-10-14T18:22:52.931Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}